4//SEC Filing
Lupien Pamela J 4
Accession 0001123292-07-000547
CIK 0000873591other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:30 PM ET
Size
20.5 KB
Accession
0001123292-07-000547
Insider Transaction Report
Form 4
Lupien Pamela J
SVP, Human Resources
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-06-18−25,000→ 0 totalExercise: $29.34Exp: 2013-02-20→ Common Stock (25,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−35,000→ 0 totalExercise: $24.17Exp: 2015-02-15→ Common Stock (35,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−60,000→ 0 totalExercise: $36.78Exp: 2016-02-22→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−30,000→ 0 totalExercise: $39.33Exp: 2012-04-01→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−15,000→ 0 totalExercise: $34.93Exp: 2015-11-08→ Common Stock (15,000 underlying)
Footnotes (7)
- [F1]This option, which provided for vesting with respect to 1/4 of the shares on 04/01/2003 and with respect to the remaining shares in equal quarterly installments thereafter, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $18.67 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F2]This option, which provided for vesting in equal quarterly installments beginning 05/20/2003, was cancelled in the merger in exchange for a cash payment of $28.66 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F3]This option, which provided for vesting in equal quarterly installments beginning 6/4/2004, was cancelled in the merger in exchange for a cash payment of $34.55 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F4]This option, which provided for vesting in equal quarterly installments beginning 05/16/2005, was cancelled in the merger in exchange for a cash payment of $33.83 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F5]This option, which provided for vesting in equal quarterly installments beginning 02/9/2006, was cancelled in the merger in exchange for a cash payment of $23.07 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F6]This option, which provided for vesting in equal quarterly installments beginning 5/23/2006, was cancelled in the merger in exchange for a cash payment of $21.22 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F7]This option, which provided for vesting in equal quarterly installments beginning 05/15/2007, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share.
Documents
Issuer
MEDIMMUNE INC /DE
CIK 0000873591
Entity typeother
Related Parties
1- filerCIK 0001328630
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:30 PM ET
- Size
- 20.5 KB